Page last updated: 2024-11-02

pentoxifylline and Dermatomyositis

pentoxifylline has been researched along with Dermatomyositis in 3 studies

Dermatomyositis: A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)

Research Excerpts

ExcerptRelevanceReference
"Ten dogs diagnosed with familial canine dermatomyositis based on clinical findings and skin biopsy results were treated PO with pentoxifylline (25 mg/kg twice daily) for 3 months."9.10Therapeutic response to pentoxifylline and its active metabolites in dogs with familial canine dermatomyositis. ( Boothe, DM; Rees, CA, 2003)
"Ten dogs diagnosed with familial canine dermatomyositis based on clinical findings and skin biopsy results were treated PO with pentoxifylline (25 mg/kg twice daily) for 3 months."5.10Therapeutic response to pentoxifylline and its active metabolites in dogs with familial canine dermatomyositis. ( Boothe, DM; Rees, CA, 2003)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rees, CA1
Boothe, DM1
Person, JR1
Asanuma, Y1
Yamada, H1
Matsuda, T1
Hoshi, K1
Ichikawa, Y1
Mizushima, Y1
Niimi, H1

Trials

1 trial available for pentoxifylline and Dermatomyositis

ArticleYear
Therapeutic response to pentoxifylline and its active metabolites in dogs with familial canine dermatomyositis.
    Veterinary therapeutics : research in applied veterinary medicine, 2003,Fall, Volume: 4, Issue:3

    Topics: Administration, Oral; Animals; Dermatomyositis; Dog Diseases; Dogs; Female; Genetic Predisposition t

2003

Other Studies

2 other studies available for pentoxifylline and Dermatomyositis

ArticleYear
Dermatomyositis responding to pentoxifylline.
    The British journal of dermatology, 1996, Volume: 134, Issue:3

    Topics: Dermatologic Agents; Dermatomyositis; Female; Humans; Middle Aged; Pentoxifylline

1996
[Successful treatment of interstitial pneumonia with lipo-PGE1 and pentoxifylline in a patient with dermatomyositis].
    Ryumachi. [Rheumatism], 1997, Volume: 37, Issue:5

    Topics: Alprostadil; Dermatomyositis; Drug Carriers; Drug Therapy, Combination; Female; Humans; Lipids; Lung

1997